Jacob Ridder, PA
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $8,533 of the $12,058 with a category attached, or 70.8%. It is spread thinly across 24 manufacturers, the largest accounting for just 12.8%. 2025 is the largest year on record at $4,369, 3.7 times the $1,187 reported in 2021. Among medical clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 546 payments — averaging $22.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Regeneron$1K
- Arcutis Biotherapeutics, Inc.$1K
- Pfizer$1K
- Sanofi$1K
- Regeneron Healthcare Solutions, Inc.$1K
- plus $5K from 18 others
What the payments were for
- Consulting fees$2,77623%
- Food & beverage$8,53371%
- Education$7496%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 99 | $1,542 |
| Regeneron | 4 | $1,449 |
| Arcutis Biotherapeutics, Inc. | 7 | $1,258 |
| Pfizer | 135 | $1,094 |
| Sanofi | 22 | $1,041 |
| Regeneron Healthcare Solutions, Inc. | 36 | $1,038 |
| Sun Pharmaceutical Industries Inc. | 31 | $727 |
| Lilly USA, LLC | 44 | $698 |
| Incyte Corporation | 36 | $680 |
| Amgen | 29 | $578 |
| Novartis | 23 | $459 |
| E.r. Squibb & Sons, L.L.C. | 28 | $410 |
| Johnson & Johnson | 13 | $379 |
| UCB, Inc. | 16 | $269 |
| LEO Pharma Inc. | 6 | $145 |
| Galderma Laboratories, L.p. | 5 | $76 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $51 |
| Botanix SB Inc | 2 | $36 |
| Genentech USA, Inc. | 1 | $34 |
| Dermavant Sciences, Inc. | 2 | $27 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Organon | 1 | $15 |
| Dermira, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,058 in reported general payments places this provider in the 95th percentile of 216 medical providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 40 | $154,071 |
| Taltz AutoinjectorIxekizumab | 11 | $78,559 |
| Fluorouracil | 45 | $4,027 |
| Clobetasol Propionate | 83 | $3,640 |
| Ketoconazole | 187 | $2,739 |
| Metronidazole | 53 | $2,486 |
| Tacrolimus | 13 | $1,440 |
| Triamcinolone Acetonide | 96 | $761 |
| Hydrocortisone | 167 | $755 |
| Mupirocin | 88 | $746 |
| Clindamycin Phosphate | 29 | $726 |
| Mometasone Furoate | 27 | $673 |
| Cephalexin | 23 | $256 |
| Nystatin | 16 | $229 |
| Minoxidil | 15 | $211 |
Paid to pharmacies, not to this prescriber.
Other medical in Omaha
- Kelly HooverOmaha$16K
- Angelika StevensOmaha$8K
- Jennelea MontanezOmaha$8K
- Kristina DadaOmaha$7K
- Saundra BrennanOmaha$6K
- Collin HortonOmaha$6K
- Karla LessmanOmaha$5K
- Lynn McLaughlinOmaha$4K
- Hannah PickOmaha$4K
- Rebecca BertucciOmaha$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.